7 news items
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
CGTX
21 May 24
, maintain relationships with suppliers and retain our management and key employees; our ability to successfully advance our current and future product
Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
CGTX
7 May 24
existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our management and key employees; our
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease
CGTX
22 Apr 24
to: competition; our ability to secure new (and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
CGTX
2 Apr 24
to secure new (and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
CGTX
26 Mar 24
ability to secure new (and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our
mzlb7hb2g35k e30jvq
CGTX
15 Mar 24
(and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our management and key
vtitsguy3g1ccuyo2abr1r4a43q138bofvanhlne
CGTX
6 Mar 24
, maintain relationships with suppliers and retain our management and key employees; our ability to successfully advance our current and future product
- Prev
- 1
- Next